Prophylactic high-dose Nω-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-α challenge in dogs

Shock

Volumn 23, Issue 3, 2005, Pages 281-288

  Sevransky, Jonathan ^a,b   Vandivier, R William ^a   Gerstenberger, Eric ^a   Correa, Rosalee ^a   Ferantz, Victor ^a   Banks, Steven M ^a   Danner, Robert L ^a   Eichacker, Peter Q ^a   Natanson, Charles ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac function; N monomethyl L arginine; Nitric oxide; Nitric oxide synthase; Tumor necrosis factor

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; DIASTOLE; DOG; DRUG MEGADOSE; HEART DISEASE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION TIME; NONHUMAN; PULMONARY ARTERY; RANDOMIZATION; SCINTISCANNING; THERMODILUTION;

ANIMALS; BLOOD PRESSURE; DOGS; ENZYME INHIBITORS; HEART DISEASES; HEART RATE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 14344250345     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000152973.78297.3b     Document Type: Article

References (34)

1. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989.
2. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984.
3. Murray DR, Freeman GL: Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 75:154-160, 1996.
4. Walley KR, Hebert PC, Wakai Y, Wilcox PG, Road JD, Cooper DJ: Decrease in left ventricular contractility after tumor necrosis factor-α infusion in dogs. J Appl Physiol 76:9-99, 1994.
5. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-664, 1987.
6. Sevransky JE, Shaked G, Novogrodsky A, Levitzki A, Gazit A, Hoffman A, Elin RJ, Quezado ZMN, Freeman BD, Eichacker PQ, Danner RL, Banks SM, Bacher J, Thomas ML, and Natanson C: Tyrphostin AG556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. J Clin Invest 99:1966-1973, 1997.
7. Levine B, Kalman J, Mayer H: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241, 1990.
8. Matsumori A, Yamada T, Suzukim H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72:561-566, 1994.
9. Nusslerm AK, Billiar TR: Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 54:171-178, 1993.
10. Ungureanu-Longrois D, Balligand JL, Simmons WW, et al.: Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to α-adrenergic agonists. Circ Res 77:494-502, 1995.
11. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokine on the heart mediated by nitric oxide. Science 257:387-389, 1992.
12. Brady AJB, Poole-Wilson PA, Wilson SE, Harding SE, Warren JB: Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963-H1966, 1992.
13. Balligand JL, Ungureanu D, Kelly RA, et al.: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 87:1964-1968, 1993.
14. Decking UKM, Flesche CW, Godecke A, Schrader J: Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 268:H2460-H2465, 1998.
15. Quezado ZMN, Karzai W, Danner RL, Freeman BD, Yan L, Eichacker PQ, Banks SM, Cobb JP, Cunnion RE, Quezado MJN, Sevransky JE, and Natanson C: Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs. Am J Respir Crit Care Med 157:1397-1405, 1998.
16. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
17. Avontour JA, Biewenga M, Bujik SL, Kanhai KJ, Bruining HA: Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock. Shock 9:451-454, 1993.
18. López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfe L, Breen D, Silverman M S, Takala J, Donaldson J, Arneson C, Grove G, Grossman S Grover R: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30, 2004.
19. Broccard A, Hurni JM, Eckert P, Liaudet L, Schaller MD, Lazor R, Perret C, Feihl F: Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock 14:35-40, 2000.
20. Kilbourn RG, Fonseca G, Price K, Ewer M, Griffitho: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
21. Eichenholz PW, Eichacker PG, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C: Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 263:H668-H675, 1992.
22. Radomski MW, Palmer RM, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87:10043-10047, 1990.
23. Chu A, Chanbers DE, Lin CC, Kuehl WD, Palmer RM, Moncada S, Cobb FR: Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 87:1964-1968, 1991.
24. Hussein Z, Beerahee M, Grover R, Jordan B, Jeffs R, Donaldson J, Zaccardelli D, Colice G, Gutupalli K, Watson D, Vincent JL: Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock. Clin Pharmacol Ther 65:1-9, 1999.
25. Cox DR: Cox regression models and life tables. J Stat Soc 34:187-220, 1972.
26. Snedecor GW: Cochran Statistical Methods, Ed 7th. Ames, IA: Iowa State University Press, 1980.
27. Fisher RA: Statistical Methods for Research Workers. Darien, CT: Hafner, 1970.
28. Seber GA: Multivariate Observations. New York: Wiley, 1984.
29. Dixon WJ: Analysis of extreme values. Ann Math Stat 21:488, 1950.
30. Feneley MP, Skelton TN, Kisslo KB, Davis JW, Bashore TM, Rankin JS: Comparison of preload recruitable stroke work, end-systolic pressure-volume and dP/dt max-end diastolic volume relations as indexes of left ventricular contractile performance in patients undergoing routine cardiac catheterization. J Am Coll Cardiol 19:1522-1530, 1992.
31. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL: Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92:2302-2312, 1993.
32. Oral H, Dorn GW, Mann DL: Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272:4836-4842, 1996.
33. Matejovic M, Krouzecky A, Martinkova V, Rokyta R, Kralova H, Treska V, Radermacher P, Novak I: Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 21:458-465, 2004.
34. 2-exchange and energy metabolism during hyperdynamic porcine endotoxemia. Shock 16:203-210, 2001.